A Diagnostic Framework for Interstitial Cystitis/Bladder (IC/BPS) Pain Syndrome in Men

This white paper presents a structured clinical framework designed to address the persistent diagnostic challenges associated with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) in male patients. Traditionally, male pelvic pain is frequently misdiagnosed as chronic bacterial prostatitis or chronic pelvic pain syndrome (CP/CPPS), leading to ineffective treatment cycles and the systemic over-prescription of antibiotics. This document proposes a definitive four-phase diagnostic algorithm that prioritizes the "diagnosis of exclusion" to ensure clinical accuracy and patient safety. The framework is specifically engineered for implementation within the Moroccan clinical environment. It achieves this by utilizing diagnostic tools and laboratory procedures—such as multiplex PCR for atypical pathogens, 48-hour extended urine cultures, and renal-bladder ultrasound—that are widely available and accessible within both public university hospitals and private urological practices in the region. Methodology The algorithm utilizes a "gated" logic system to guide clinicians through a systematic workup: Phase 0 (Emergency Gate): Immediate screening for urological emergencies and "red flag" symptoms to ensure patient stabilization. Phase 1 (Pseudo-IC Exclusion): Rigorous screening for identifiable mimics, including urinary tract infections, sexually transmitted infections, urolithiasis, and malignancy. Phase 2 (Tri-Axial Differentiation): A comparative evaluation of the three primary pain generators in the male pelvis: the bladder (luminal), the prostate (glandular), and the pelvic floor (myofascial). Phase 3 (Functional Testing): Objective confirmatory testing using a standardized lidocaine challenge (intravesical instillations) to measure immediate analgesic response. Phase 4 (Classification): Final categorization of the patient into phenotype-specific cohorts (e.g., Hunner-type IC, Non-Hunner IC, or Myofascial Pain) to dictate targeted therapy. Practical Impact and Value Clinical Standardization: Provides a reproducible, evidence-based pathway for urologists to transition from subjective assessment to objective diagnosis. Antimicrobial Stewardship: Directly combats antibiotic resistance by mandating objective proof of infection before the initiation of antimicrobial therapy. Socio-Economic Efficiency: Optimizes the use of existing healthcare resources by prioritizing high-yield diagnostic tests that are compatible with national insurance coverage (AMO). Safety Integration: Establishes mandatory pharmacological caps and procedural guardrails to prevent iatrogenic injury and systemic toxicity during diagnostic maneuvers. This framework serves as a foundational resource for urologists, general practitioners, and healthcare policy-makers seeking to improve the quality of care and diagnostic precision for men suffering from chronic pelvic pain. Keywords Urology, Interstitial Cystitis, Bladder Pain Syndrome, Male Pelvic Pain, Diagnostic Algorithm, Clinical Localization, Morocco, Prostatitis, Diagnosis of Exclusion, Lidocaine Challenge.